SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 6.15 |
Enterprise Value ($M) | 13.27 |
Book Value ($M) | 18.02 |
Book Value / Share | 1.30 |
Price / Book | 0.34 |
NCAV ($M) | -7.70 |
NCAV / Share | -0.56 |
Price / NCAV | -0.80 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.53 |
Return on Assets (ROA) | -0.48 |
Return on Equity (ROE) | -0.58 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.33 |
Current Ratio | 1.37 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5.65 |
Assets | 31.37 |
Liabilities | 13.35 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D | Taiwan Carbon Nano Technology Corp | 40.23 | ||
13D/A | Ainos Inc | 17.97 | -16.41 | |
13D | Advanced Semiconductor Engineering Inc | 27.40 | ||
13D/A | Amarillo Biosciences Inc | 63.36 | 76.37 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
U.S. Securities and Exchange Commission Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
8,540 | 26,674 | 32.02 | |
66,714 | 128,810 | 51.79 | |
33,095 | 59,132 | 55.97 | |
39,935 | 84,599 | 47.21 | |
13,778 | 26,345 | 52.30 | |
(click for more detail) |
Similar Companies | |
---|---|
ADTX – Aditxt, Inc. | ADVM – Adverum Biotechnologies, Inc. |
AGEN – Agenus Inc. | AKAN – Akanda Corp. |
AKBA – Akebia Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io